Nuzyra
Payments companies reported to CMS as associated with Nuzyra. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Nuzyra, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Nuzyra
These are the largest totals companies reported as associated with Nuzyra. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Andrew Dold | Dacula, GA | Infectious Disease | $451,720.03 |
| Warren Joseph | Phoenix, AZ | Primary Podiatric Medicine | $266,360.81 |
| Yoav Golan | Boston, MA | Infectious Disease | $214,668.33 |
| David Wu | West Chester, PA | Infectious Disease | $204,957.50 |
| Christian Sandrock | Sacramento, CA | Internal Medicine | $115,385.26 |
| George Sakoulas | San Diego, CA | Infectious Disease | $105,034.06 |
| James Swiencicki | Williamsville, NY | Infectious Disease | $100,958.72 |
| Hector Brunet Rodriguez | Shreveport, LA | Infectious Disease | $94,965.87 |
| Timothy Franson | Zionsville, IN | Infectious Disease | $92,695.57 |
| William Harley | Charlotte, NC | Infectious Disease | $59,906.25 |
Prescribed Nuzyra?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.